Relmada Therapeutics Inc Stock Performance
as on October 23, 2025 at 1:29 am IST
Day's Low
Day's High
$1.98$2.26
7.48%
Downside
5.61%
Upside
52 Week's Low
52 Week's High
$0.24$3.9888.77%
Downside
85.98%
Upside
Relmada Therapeutics Inc share price movements today
- Previous Close
- $2.24
- Open
- $2.25
- Volume
- 689.8K
- Day's Low - High
- $1.98 - $2.26
- 52 Week Low - High
- $0.24 - $3.98
Relmada Therapeutics Inc Historical Returns
- 1 Month Return
- + 35.76 %
- 3 Month Return
- + 258.11 %
- 1 Year Return
- -38.46 %
- 3 Year Return
- -68.05 %
- 5 Year Return
- -93.28 %
Relmada Therapeutics Inc Stock Fundamentals & Key Indicators
Check Relmada Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$75.0M
EPS (TTM)
-1.15
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-161.2M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
14967200.00%
Relmada Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Relmada Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $75.0M | -93.28% | NA | 0.00% | |
| BUY | $64.4B | 252.94% | -505.15 | -12.96% | |
| NA | $35.3B | NA | NA | -3.89% | |
| BUY | $107.5B | 102.91% | 29.68 | 31.86% | |
| BUY | $61.3B | 0.63% | 14.58 | 31.37% |
Stock Returns calculator for Relmada Therapeutics Inc Stock including INR - Dollar returns
The Relmada Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Relmada Therapeutics Inc investment value today
Current value as on today
₹63,349
Returns
Returns from Relmada Therapeutics Inc Stock
Dollar Returns*
₹4,557 (+4.56%)
Analyst Recommendation on Relmada Therapeutics Inc Stock
Based on 11 analysts
63.64%
Buy
36.36%
Hold
0.00%
Sell
Based on 11 analysts, 63.64% of analysts recommend a 'BUY' rating for Relmada Therapeutics Inc. Average target price of $1
Relmada Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Relmada Therapeutics Inc.
What analysts predicted
-114%DOWNSIDE
Target Price
$1
Current Price
$2.14
Analyzed by
11 Analysts
Target
$1.00
Relmada Therapeutics Inc target price $1, a slight downside of -114% compared to current price of $2.14. According to 11 analysts rating.
Relmada Therapeutics Inc Stock’s Investor Sentiment and Interest
Search interest for Relmada Therapeutics Inc Stock has decreased by -26% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Relmada Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Relmada Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Relmada Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Relmada Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Insights on Relmada Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 3 months, RLMD stock has moved up by 258.1%
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 138.3% return, outperforming this stock by 206.3%
- NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 59.9% return, outperforming this stock by 98.4%
About Relmada Therapeutics Inc
| Organisation | Relmada Therapeutics Inc |
| Headquarters | 2222 Ponce de Leon Blvd., Coral Gables, FL, United States, 33134 |
| Industry | Pharmaceuticals: Major |
| CEO | Dr. Sergio Traversa M.B.A., Pharm.D. |
| E-voting on shares | Click here to vote |
Key Management of Relmada Therapeutics Inc
Name | Title |
|---|---|
Dr. Sergio Traversa M.B.A., Pharm.D. | CEO & Director |
Mr. Maged S. Shenouda M.B.A., R.Ph. | Chief Financial Officer |
Mr. Paul E. Kelly M.B.A. | COO & Director |
Mr. Charles S. Ence CPA, M.B.A. | Chief Accounting & Compliance Officer |
Ms. Gina DiGuglielmo | VP & Head of Clinical Operations |
Dr. Raj S. Pruthi F.A.C.S., M.D., M.H.A. | Chief Medical Officer of Urology |
Dr. Andrew Cutler | Senior Clinical Development Advisor |
Dr. Richard M. Mangano Ph.D. | Consultant |
FAQs
What is Relmada Therapeutics Inc share price today?
Relmada Therapeutics Inc share price today is $2.14 as on at the close of the market. Relmada Therapeutics Inc share today touched a day high of $2.26 and a low of $1.98.
What is the 52 week high and 52 week low for Relmada Therapeutics Inc share?
Relmada Therapeutics Inc share touched a 52 week high of $3.98 on and a 52 week low of $0.24 on . Relmada Therapeutics Inc stock price today i.e. is closed at $2.14,which is 46.23% down from its 52 week high and 790.18% up from its 52 week low.
What is Relmada Therapeutics Inc's market capitalisation today?
Relmada Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in Relmada Therapeutics Inc Stock (RLMD) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Relmada Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Relmada Therapeutics Inc Shares that will get you 0.7009 shares as per Relmada Therapeutics Inc share price of $2.14 per share as on October 23, 2025 at 1:29 am IST.
What is the minimum amount required to buy Relmada Therapeutics Inc Stock (RLMD) from India?
Indian investors can start investing in Relmada Therapeutics Inc (RLMD) shares with as little as ₹87.755 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹877.55 in Relmada Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Relmada Therapeutics Inc share’s latest price of $2.14 as on October 23, 2025 at 1:29 am IST, you will get 4.6729 shares of Relmada Therapeutics Inc. Learn more about
fractional shares .
What are the returns that Relmada Therapeutics Inc has given to Indian investors in the last 5 years?
Relmada Therapeutics Inc stock has given -93.28% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?